Pathways’ Picks November 11: DC in Transition, and More to Watch

article image

In this week’s roundup: a look at some key issues for medtech amid the US post-election morass, and notable medtech policy developments from around the globe.

The US presidential election has been independently called for Joe Biden, and his transition team is kicking into gear to ready its policy plans in advance of the January 20 inauguration. Meanwhile, President Trump has yet to concede the election, causing more than the anticipated level of transition-period complications and confusion. And control of the Senate won’t be decided until January, with two runoff elections in Georgia. In this week’s Pathways’ Picks, first, some key medtech matters to watch amid the post-election muddle. And then a look at important non-election policy developments from around the globe.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: